InnoCare Pharma Limited (HKG: 9969)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.71
-0.11 (-1.61%)
Oct 9, 2024, 4:08 PM HKT

InnoCare Pharma Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-470.89-631.26-886.59-64.55-391.4-2,141
Upgrade
Depreciation & Amortization
87.7986.2668.833.0811.198.67
Upgrade
Other Amortization
14.6713.129.850.630.271.38
Upgrade
Loss (Gain) From Sale of Assets
---0--
Upgrade
Asset Writedown & Restructuring Costs
8.320.02-6.77---
Upgrade
Loss (Gain) From Sale of Investments
-7.13-5.571.44-6.7--
Upgrade
Loss (Gain) on Equity Investments
---0.6--
Upgrade
Stock-Based Compensation
19.8465.1129.48126.44215.6265.8
Upgrade
Provision & Write-off of Bad Debts
0.970.270.1---
Upgrade
Other Operating Activities
-134.6349.17200.51-40.7548.351,965
Upgrade
Change in Accounts Receivable
-152.9-194.53-24.56-45.15-0.120.01
Upgrade
Change in Inventory
5.11-42.46-52.12-8.04-1.88-
Upgrade
Change in Accounts Payable
-9.58-5.6169.2879.08-2.686
Upgrade
Change in Unearned Revenue
---17.19-51.39-3.45
Upgrade
Change in Other Net Operating Assets
---75.22-0.4918.68
Upgrade
Operating Cash Flow
-638.44-665.49-490.58167.06-172.52-79.75
Upgrade
Capital Expenditures
-196.87-254.65-370.33-169.77-251-74.57
Upgrade
Sale of Property, Plant & Equipment
0.010.01-0.02--
Upgrade
Cash Acquisitions
1.151.15----
Upgrade
Sale (Purchase) of Intangibles
----1.44-0.27-0.46
Upgrade
Investment in Securities
-1,058795.85-1,529-1,638-889.0318.73
Upgrade
Other Investing Activities
171.57118.7198.3779.5733.34103.77
Upgrade
Investing Cash Flow
-1,082661.06-1,801-1,730-1,10747.47
Upgrade
Long-Term Debt Issued
-33.832550--
Upgrade
Total Debt Issued
31.233.832550--
Upgrade
Short-Term Debt Repaid
-----9.02-
Upgrade
Long-Term Debt Repaid
--28.98-21.77-14.92-4.99-56.85
Upgrade
Total Debt Repaid
-59.22-28.98-21.77-14.92-14.02-56.85
Upgrade
Net Debt Issued (Repaid)
-28.024.82303.2335.08-14.02-56.85
Upgrade
Issuance of Common Stock
12.379.952,9232,5272,3569.34
Upgrade
Repurchase of Common Stock
-6.3-6.3----
Upgrade
Common Dividends Paid
-0.31-1.15-3.26---
Upgrade
Other Financing Activities
-10.26-6.01-128.69-17.74-103.87-2.22
Upgrade
Financing Cash Flow
-32.521.313,0952,5452,238362.94
Upgrade
Foreign Exchange Rate Adjustments
-26.0225.7139.9-45.3-251.7818.29
Upgrade
Net Cash Flow
-1,77922.58942.5936.6706.73348.95
Upgrade
Free Cash Flow
-835.31-920.14-860.91-2.71-423.51-154.32
Upgrade
Free Cash Flow Margin
-106.99%-124.59%-137.66%-0.26%-31049.41%-12375.46%
Upgrade
Free Cash Flow Per Share
-0.50-0.54-0.58-0.00-0.44-0.67
Upgrade
Cash Interest Paid
---2.531.142.22
Upgrade
Cash Income Tax Paid
58.7858.7818.89---
Upgrade
Levered Free Cash Flow
-959.82-837.22-160.4435.82-412.99-150.83
Upgrade
Unlevered Free Cash Flow
-944.05-815.21-149.5737.47-412.28-150.62
Upgrade
Change in Net Working Capital
431.65282.45-469.26-162.638.72-23.9
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.